Intercept’s NASH Approval Timeline Shuffled Again With FDA Delay

 
• By Joseph Haas
Business time concept as a group of running businessmen and businesswomen using a giant clock to cross over a cliff as a bridge as a metaphor for schedule and appointment speed as a 3D illustration.
Intercept's timeline for OCA approval in NASH remains uncertain

More from New Products

More from Scrip